Gender Differences

Carlos M Ferrario, MD, FAHA, FASH, FACC Dewitt-Cordelll Professor of Surgical Sciences Professor, Internal Medicine-Nephrology Professor, Physiology-Pharmacology Wake Forest University School of Medicine Winston-Salem, NC 27157-1032 Vice-President, Consortium Southeastern Hypertension Control Editor-in-Chief Therapeutic Advances in Cardiovascular DiseaseMedicalResearch.com Interview with: Carlos M Ferrario, MD, FAHA, FASH, FACC Dewitt-Cordelll Professor of Surgical Sciences Professor, Internal Medicine-Nephrology Professor, Physiology-Pharmacology Wake Forest University School of Medicine Winston-Salem, NC 27157-1032 Vice-President, Consortium Southeastern Hypertension Control Editor-in-Chief, Therapeutic Advances in Cardiovascular Disease MedicalResearch.com: What are the main findings of the study? Dr. Ferrario: A significant and unexpected difference in the hemodynamic mechanisms that account for the elevated blood pressure between untreated hypertensive men and women. The main findings were: "Despite there being no differences between women and men in terms of office blood pressure, heart rate and body mass index, men demonstrated lower values of pulse pressure, systemic vascular resistance, brachial artery pulse wave velocity and augmentation index. In each of the three hypertension categories, the increased blood pressure in men was associated with significant augmentations in stroke volume and cardiac output compared with women. Sex-related hemodynamic differences were associated in women with higher plasma levels of leptin, hs-CRP, plasma angiotensin II and serum aldosterone. In women but not men, hs-CRP correlated with plasma concentrations of transforming growth factor β1 (TGFβ1) and body weight; in addition, plasma TGFβ1 correlated with levels of serum vascular cell adhesion molecule 1."

Mike Head Network Manager Infectious Disease Research NetworkMedicalResearch.com Interview with: Mike Head Network Manager Infectious Disease Research Network MedicalResearch.com: What are the main findings of the study? Answer: The differences in total funding received between male and female principal investigators (PIs) is considerable. This can be partially explained by there being far more male senior scientists than female. But this in itself is not ideal, and there are two further causes for concern: 1. The median award size - male PIs receive larger awards than female PIs, across virtually every topic area and type of science. 2. The differences in median award size and total funding awarded by gender remain virtually unchanged across the fourteen years of this dataset. The gap is not closing.

MedicalResearch.com Interview with: Guy Fagherazzi, PhD Epidemiologist Scientific manager – E4N cohort study (www.e4n.fr) Inserm U1018 Team 9 Nutrition,hormones and women’s healthGuy Fagherazzi, PhD Epidemiologist Scientific manager – E4N cohort study (www.e4n.fr) Inserm U1018 Team 9 Nutrition,hormones and women’s health MedicalResearch.com: What are the main findings of the study?
 Dr. Fagherazzi: Our study of more than 60 000 French women from the E3N cohort study has shown that higher overall acidity of the diet, regardless of the individual foods making up that diet, was associated with a higher risk of type 2 diabetes.

Joshua Lewis, Ph.D Raine Foundation / Alan Robson Fellow Bone and Vascular Research Group School of Medicine and Pharmacology University of Western Australia Department of Endocrinology and Diabetes Sir Charles Gairdner Hospital Hospital Avenue, Nedlands 6009MedicalResearch.com Interview with: Joshua Lewis, Ph.D Raine Foundation / Alan Robson Fellow Bone and Vascular Research Group School of Medicine and Pharmacology University of Western Australia Department of Endocrinology and Diabetes Sir Charles Gairdner Hospital Hospital Avenue, Nedlands 6009 www.boneandvascularresearch.org.au MedicalResearch.com: What are the main findings of the study? Dr. Lewis: The paper reports the findings from an ancillary study of the effects of 1200 mg per day of calcium supplementation on a major predictor of heart disease risk, carotid artery intima-medial thickness and atherosclerosis. The principle study was a large five-year double blind randomized controlled trial of calcium supplements or a placebo. After 3 years of calcium supplementation or placebo measures of carotid artery intima-medial thickness were identical in the placebo and calcium treated patients.  Atherosclerotic plaque was reduced in calcium treated patients when analysed as total calcium intake. These findings argue strongly against an adverse effect of high dose calcium tablets on cardiovascular risk.

MedicalResearch.com Interview with: Dr. W.M. Lijfering, MD, PhD Department of Clinical Epidemiology, C7-P-89 Leiden University Medical Center PO Box 9600 2300 RC LeidenDr. W.M. Lijfering, MD, PhD Department of Clinical Epidemiology, C7-P-89 Leiden University Medical Center PO Box 9600 2300 RC Leiden   MedicalResearch.com: What are the main findings of the study? Dr. Lijfering: In this study we found that the risk of a first venous thrombosis* is two-fold higher in men than in women once female reproductive risk factors for venous thrombosis are taken into account (odds ratio 1.9, 95% CI 1.7-2.2). These results were found in all age categories (18-70 years) and were not affected by adjustment for body mass index and smoking, or by excluding participants with malignancy.